Can I read PD - L1 As A Biomarker of Response To Immune - Checkpoint Inhibitors on EtoBox?

PD - L1 As A Biomarker of Response To Immune - Checkpoint Inhibitors by emilybatmanmahony is a document available to read on EtoBox.

What is PD - L1 As A Biomarker of Response To Immune - Checkpoint Inhibitors about?

This review discusses the role of PD-L1 as a biomarker for predicting response to immune-checkpoint inhibitors in cancer treatment. It highlights the challenges associated with PD-L1 immunohistochemistry assays, including variability in performance and the need for standardization. The authors emphasize the importance of selecting appropriate assays based on clinical utility and the necessity for further research to optimize PD-L1 as a predictive biomarker for patients with solid tumors.

Author

emilybatmanmahony

Language

EN